Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-05-22

Clinical Trial Update: Home Use Sensor Study [NA]

View source ↗

Summary

Clinical trial update for a home-use sensor study in diabetes management sponsored by Senseonics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eversense CGM (continuous glucose monitor)

Snippet

Sponsor: Senseonics, Inc. | Conditions: Diabetes Mellitus | NA | Status: UNKNOWN